ResearcherWuhan Union HospitalActive in the last 2 years

Feng Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5358-2222; OpenAlex author ID A5101901194. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Preclinical Development and Comparison of [99mTc]Tc/[177Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Cancer Theranostics. Co-author DOI 10.1021/acs.molpharmaceut.5c01039 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongkang Gai · 1 shared paper, 2025 · strength 0.23
- Paper Preclinical Development and Comparison of [99mTc]Tc/[177Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Canc… DOI 10.1021/acs.molpharmaceut.5c01039 ↗
Dawei Jiang · 1 shared paper, 2025 · strength 0.23
- Paper Preclinical Development and Comparison of [99mTc]Tc/[177Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Canc… DOI 10.1021/acs.molpharmaceut.5c01039 ↗
Xiaoli Lan · 1 shared paper, 2025 · strength 0.23
- Paper Preclinical Development and Comparison of [99mTc]Tc/[177Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Canc… DOI 10.1021/acs.molpharmaceut.5c01039 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.